Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist
- 31 July 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (5) , 729-733
- https://doi.org/10.1016/s0006-2952(00)00361-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacological characterization of antagonists of the C5a receptorBritish Journal of Pharmacology, 1999
- Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5aJournal of Medicinal Chemistry, 1999
- Effects of a new C5a receptor antagonist on C5a- and endotoxin- induced neutropenia in the ratBritish Journal of Pharmacology, 1999
- Small Molecular Probes for G-Protein-Coupled C5a Receptors: Conformationally Constrained Antagonists Derived from the C Terminus of the Human Plasma Protein C5aJournal of Medicinal Chemistry, 1998
- Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifisEuropean Journal of Clinical Investigation, 1998
- Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide‐stimulated monocytes and macrophagesEuropean Journal of Immunology, 1990
- C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.The Journal of Experimental Medicine, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Motility, cell shape, and locomotion of neutrophil granulocytesCell Motility, 1983
- THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTESThe Journal of Experimental Medicine, 1962